Warning! GuruFocus detected
1 Severe warning sign
with INTI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Inhibitor Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US42278K1025
Description
Inhibitor Therapeutics Inc is a pharmaceutical development company that is focused on developing and ultimately commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delivery for patients with certain cancers and certain non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.35 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -175.9 | |||||
| 3-Year EPS without NRI Growth Rate | -171.4 | |||||
| 3-Year FCF Growth Rate | -166.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.53 | |||||
| 9-Day RSI | 28.62 | |||||
| 14-Day RSI | 31.49 | |||||
| 3-1 Month Momentum % | 8.33 | |||||
| 6-1 Month Momentum % | -27.7 | |||||
| 12-1 Month Momentum % | -4.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.02 | |||||
| Quick Ratio | 8.02 | |||||
| Cash Ratio | 7.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -85.85 | |||||
| ROA % | -46.31 | |||||
| ROIC % | -11081.82 | |||||
| ROC (Joel Greenblatt) % | -11081.82 | |||||
| ROCE % | -53.08 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.5 | |||||
| Price-to-Tangible-Book | 5.5 | |||||
| EV-to-EBIT | -0.66 | |||||
| EV-to-EBITDA | -0.66 | |||||
| EV-to-FCF | -0.74 | |||||
| Price-to-Projected-FCF | 2.75 | |||||
| Price-to-Net-Current-Asset-Value | 5.5 | |||||
| Price-to-Net-Cash | 5.5 | |||||
| Earnings Yield (Greenblatt) % | -151.52 | |||||
| FCF Yield % | -34.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inhibitor Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.021 | ||
| Beta | -0.42 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.13 | ||
| Volatility % | 54.33 | ||
| 14-Day RSI | 31.49 | ||
| 14-Day ATR ($) | 0.004992 | ||
| 20-Day SMA ($) | 0.064033 | ||
| 12-1 Month Momentum % | -4.83 | ||
| 52-Week Range ($) | 0.0411 - 0.1376 | ||
| Shares Outstanding (Mil) | 172.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inhibitor Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inhibitor Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inhibitor Therapeutics Inc Frequently Asked Questions
What is Inhibitor Therapeutics Inc(INTI)'s stock price today?
The current price of INTI is $0.06. The 52 week high of INTI is $0.14 and 52 week low is $0.04.
When is next earnings date of Inhibitor Therapeutics Inc(INTI)?
The next earnings date of Inhibitor Therapeutics Inc(INTI) is .
Does Inhibitor Therapeutics Inc(INTI) pay dividends? If so, how much?
Inhibitor Therapeutics Inc(INTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers